The global market for Blood-derived Products was valued at US$ 9375 million in the year 2024 and is projected to reach a revised size of US$ 14340 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Blood-derived Products Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Blood-derived Products competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Blood-derived products, also known as Hemoderivatives, are therapeutic or diagnostic substances obtained from human or animal blood, primarily from plasma. Through industrial-scale fractionation, valuable proteins such as albumin, immunoglobulins, and coagulation factors are isolated for clinical use. These products are essential in treating a variety of conditions, including immune deficiencies, hemophilia, and surgical bleeding. Due to their biological origin, hemoderivatives are subject to strict regulations to ensure viral safety, traceability, and consistent quality. They play a vital role in modern medicine, especially in intensive care, transfusion therapy, and rare disease management.

The Human Bloodm Albumin market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, Human Bloodm Albumin is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.

However, the market faces challenges such as limited plasma supply and high production costs, as Human Bloodm Albumin is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant Human Bloodm Albumin is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global Human Bloodm Albumin market.

The key global producers of Human Bloodm Albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood-derived Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood-derived Products.

The Blood-derived Products market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood-derived Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood-derived Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Blood-derived Products Market Report

Report Metric	Details
Report Name	Blood-derived Products Market
Accounted market size in year	US$ 9375 million
Forecasted market size in 2031	US$ 14340 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Albumin Immunoglobulins Coagulation Factors Others
Segment by Application	Therapeutics Excipient Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood-derived Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood-derived Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Blood-derived Products Market growing?

Ans: The Blood-derived Products Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Blood-derived Products Market size in 2031?

Ans: The Blood-derived Products Market size in 2031 will be US$ 14340 million.

What is the market share of major companies in Blood-derived Products Market?

Ans: The key global producers of Human Bloodm Albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share.

What is the CSL share in Blood-derived Products Market?

Ans: The largest producer is CSL with a market share of 21.25%.

Who are the main players in the Blood-derived Products Market report?

Ans: The main players in the Blood-derived Products Market are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang

What are the Application segmentation covered in the Blood-derived Products Market report?

Ans: The Applications covered in the Blood-derived Products Market report are Therapeutics, Excipient, Other

What are the Type segmentation covered in the Blood-derived Products Market report?

Ans: The Types covered in the Blood-derived Products Market report are Albumin, Immunoglobulins, Coagulation Factors, Others

1 Blood-derived Products Market Overview

1.1 Product Definition

1.2 Blood-derived Products by Type

1.2.1 Global Blood-derived Products Market Value Comparison by Type (2024 VS 2031)

1.2.2 Albumin

1.2.3 Immunoglobulins

1.2.4 Coagulation Factors

1.2.5 Others

1.3 Blood-derived Products by Application

1.3.1 Global Blood-derived Products Market Value by Application (2024 VS 2031)

1.3.2 Therapeutics

1.3.3 Excipient

1.3.4 Other

1.4 Global Blood-derived Products Market Size Estimates and Forecasts

1.4.1 Global Blood-derived Products Revenue 2020-2031

1.4.2 Global Blood-derived Products Sales 2020-2031

1.4.3 Global Blood-derived Products Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Blood-derived Products Market Competition by Manufacturers

2.1 Global Blood-derived Products Sales Market Share by Manufacturers (2020-2025)

2.2 Global Blood-derived Products Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Blood-derived Products Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Blood-derived Products, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Blood-derived Products, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Blood-derived Products, Product Type & Application

2.7 Global Key Manufacturers of Blood-derived Products, Date of Enter into This Industry

2.8 Global Blood-derived Products Market Competitive Situation and Trends

2.8.1 Global Blood-derived Products Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Blood-derived Products Players Market Share by Revenue

2.8.3 Global Blood-derived Products Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Blood-derived Products Market Scenario by Region

3.1 Global Blood-derived Products Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Blood-derived Products Sales by Region: 2020-2031

3.2.1 Global Blood-derived Products Sales by Region: 2020-2025

3.2.2 Global Blood-derived Products Sales by Region: 2026-2031

3.3 Global Blood-derived Products Revenue by Region: 2020-2031

3.3.1 Global Blood-derived Products Revenue by Region: 2020-2025

3.3.2 Global Blood-derived Products Revenue by Region: 2026-2031

3.4 North America Blood-derived Products Market Facts & Figures by Country

3.4.1 North America Blood-derived Products Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Blood-derived Products Sales by Country (2020-2031)

3.4.3 North America Blood-derived Products Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Blood-derived Products Market Facts & Figures by Country

3.5.1 Europe Blood-derived Products Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Blood-derived Products Sales by Country (2020-2031)

3.5.3 Europe Blood-derived Products Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Blood-derived Products Market Facts & Figures by Region

3.6.1 Asia Pacific Blood-derived Products Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Blood-derived Products Sales by Region (2020-2031)

3.6.3 Asia Pacific Blood-derived Products Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Blood-derived Products Market Facts & Figures by Country

3.7.1 Latin America Blood-derived Products Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Blood-derived Products Sales by Country (2020-2031)

3.7.3 Latin America Blood-derived Products Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Blood-derived Products Market Facts & Figures by Country

3.8.1 Middle East and Africa Blood-derived Products Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Blood-derived Products Sales by Country (2020-2031)

3.8.3 Middle East and Africa Blood-derived Products Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Blood-derived Products Sales by Type (2020-2031)

4.1.1 Global Blood-derived Products Sales by Type (2020-2025)

4.1.2 Global Blood-derived Products Sales by Type (2026-2031)

4.1.3 Global Blood-derived Products Sales Market Share by Type (2020-2031)

4.2 Global Blood-derived Products Revenue by Type (2020-2031)

4.2.1 Global Blood-derived Products Revenue by Type (2020-2025)

4.2.2 Global Blood-derived Products Revenue by Type (2026-2031)

4.2.3 Global Blood-derived Products Revenue Market Share by Type (2020-2031)

4.3 Global Blood-derived Products Price by Type (2020-2031)

5 Segment by Application

5.1 Global Blood-derived Products Sales by Application (2020-2031)

5.1.1 Global Blood-derived Products Sales by Application (2020-2025)

5.1.2 Global Blood-derived Products Sales by Application (2026-2031)

5.1.3 Global Blood-derived Products Sales Market Share by Application (2020-2031)

5.2 Global Blood-derived Products Revenue by Application (2020-2031)

5.2.1 Global Blood-derived Products Revenue by Application (2020-2025)

5.2.2 Global Blood-derived Products Revenue by Application (2026-2031)

5.2.3 Global Blood-derived Products Revenue Market Share by Application (2020-2031)

5.3 Global Blood-derived Products Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Grifols

6.1.1 Grifols Company Information

6.1.2 Grifols Description and Business Overview

6.1.3 Grifols Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Grifols Blood-derived Products Product Portfolio

6.1.5 Grifols Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Blood-derived Products Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 Takeda

6.3.1 Takeda Company Information

6.3.2 Takeda Description and Business Overview

6.3.3 Takeda Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Takeda Blood-derived Products Product Portfolio

6.3.5 Takeda Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Blood-derived Products Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 CBPO

6.5.1 CBPO Company Information

6.5.2 CBPO Description and Business Overview

6.5.3 CBPO Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.5.4 CBPO Blood-derived Products Product Portfolio

6.5.5 CBPO Recent Developments/Updates

6.6 Hualan Bio

6.6.1 Hualan Bio Company Information

6.6.2 Hualan Bio Description and Business Overview

6.6.3 Hualan Bio Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hualan Bio Blood-derived Products Product Portfolio

6.6.5 Hualan Bio Recent Developments/Updates

6.7 Kedrion

6.7.1 Kedrion Company Information

6.7.2 Kedrion Description and Business Overview

6.7.3 Kedrion Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Kedrion Blood-derived Products Product Portfolio

6.7.5 Kedrion Recent Developments/Updates

6.8 Shanghai RAAS

6.8.1 Shanghai RAAS Company Information

6.8.2 Shanghai RAAS Description and Business Overview

6.8.3 Shanghai RAAS Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Shanghai RAAS Blood-derived Products Product Portfolio

6.8.5 Shanghai RAAS Recent Developments/Updates

6.9 LFB Group

6.9.1 LFB Group Company Information

6.9.2 LFB Group Description and Business Overview

6.9.3 LFB Group Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.9.4 LFB Group Blood-derived Products Product Portfolio

6.9.5 LFB Group Recent Developments/Updates

6.10 Weiguang Bio

6.10.1 Weiguang Bio Company Information

6.10.2 Weiguang Bio Description and Business Overview

6.10.3 Weiguang Bio Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Weiguang Bio Blood-derived Products Product Portfolio

6.10.5 Weiguang Bio Recent Developments/Updates

6.11 Tiantan Bio

6.11.1 Tiantan Bio Company Information

6.11.2 Tiantan Bio Description and Business Overview

6.11.3 Tiantan Bio Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Tiantan Bio Blood-derived Products Product Portfolio

6.11.5 Tiantan Bio Recent Developments/Updates

6.12 Shuanglin Bio

6.12.1 Shuanglin Bio Company Information

6.12.2 Shuanglin Bio Description and Business Overview

6.12.3 Shuanglin Bio Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Shuanglin Bio Blood-derived Products Product Portfolio

6.12.5 Shuanglin Bio Recent Developments/Updates

6.13 Boya Bio

6.13.1 Boya Bio Company Information

6.13.2 Boya Bio Description and Business Overview

6.13.3 Boya Bio Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Boya Bio Blood-derived Products Product Portfolio

6.13.5 Boya Bio Recent Developments/Updates

6.14 Yuanda Shuyang

6.14.1 Yuanda Shuyang Company Information

6.14.2 Yuanda Shuyang Description and Business Overview

6.14.3 Yuanda Shuyang Blood-derived Products Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Yuanda Shuyang Blood-derived Products Product Portfolio

6.14.5 Yuanda Shuyang Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Blood-derived Products Industry Chain Analysis

7.2 Blood-derived Products Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Blood-derived Products Production Mode & Process Analysis

7.4 Blood-derived Products Sales and Marketing

7.4.1 Blood-derived Products Sales Channels

7.4.2 Blood-derived Products Distributors

7.5 Blood-derived Products Customer Analysis

8 Blood-derived Products Market Dynamics

8.1 Blood-derived Products Industry Trends

8.2 Blood-derived Products Market Drivers

8.3 Blood-derived Products Market Challenges

8.4 Blood-derived Products Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Blood-derived Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Blood-derived Products Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Blood-derived Products Market Competitive Situation by Manufacturers in 2024

Table 4. Global Blood-derived Products Sales (MT) of Key Manufacturers (2020-2025)

Table 5. Global Blood-derived Products Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Blood-derived Products Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Blood-derived Products Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Blood-derived Products Average Price (US$/Kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Blood-derived Products, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Blood-derived Products, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Blood-derived Products, Product Type & Application

Table 12. Global Key Manufacturers of Blood-derived Products, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Blood-derived Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood-derived Products as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Blood-derived Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Blood-derived Products Sales by Region (2020-2025) & (MT)

Table 18. Global Blood-derived Products Sales Market Share by Region (2020-2025)

Table 19. Global Blood-derived Products Sales by Region (2026-2031) & (MT)

Table 20. Global Blood-derived Products Sales Market Share by Region (2026-2031)

Table 21. Global Blood-derived Products Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Blood-derived Products Revenue Market Share by Region (2020-2025)

Table 23. Global Blood-derived Products Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Blood-derived Products Revenue Market Share by Region (2026-2031)

Table 25. North America Blood-derived Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Blood-derived Products Sales by Country (2020-2025) & (MT)

Table 27. North America Blood-derived Products Sales by Country (2026-2031) & (MT)

Table 28. North America Blood-derived Products Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Blood-derived Products Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Blood-derived Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Blood-derived Products Sales by Country (2020-2025) & (MT)

Table 32. Europe Blood-derived Products Sales by Country (2026-2031) & (MT)

Table 33. Europe Blood-derived Products Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Blood-derived Products Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Blood-derived Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Blood-derived Products Sales by Region (2020-2025) & (MT)

Table 37. Asia Pacific Blood-derived Products Sales by Region (2026-2031) & (MT)

Table 38. Asia Pacific Blood-derived Products Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Blood-derived Products Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Blood-derived Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Blood-derived Products Sales by Country (2020-2025) & (MT)

Table 42. Latin America Blood-derived Products Sales by Country (2026-2031) & (MT)

Table 43. Latin America Blood-derived Products Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Blood-derived Products Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Blood-derived Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Blood-derived Products Sales by Country (2020-2025) & (MT)

Table 47. Middle East and Africa Blood-derived Products Sales by Country (2026-2031) & (MT)

Table 48. Middle East and Africa Blood-derived Products Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Blood-derived Products Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Blood-derived Products Sales (MT) by Type (2020-2025)

Table 51. Global Blood-derived Products Sales (MT) by Type (2026-2031)

Table 52. Global Blood-derived Products Sales Market Share by Type (2020-2025)

Table 53. Global Blood-derived Products Sales Market Share by Type (2026-2031)

Table 54. Global Blood-derived Products Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Blood-derived Products Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Blood-derived Products Revenue Market Share by Type (2020-2025)

Table 57. Global Blood-derived Products Revenue Market Share by Type (2026-2031)

Table 58. Global Blood-derived Products Price (US$/Kg) by Type (2020-2025)

Table 59. Global Blood-derived Products Price (US$/Kg) by Type (2026-2031)

Table 60. Global Blood-derived Products Sales (MT) by Application (2020-2025)

Table 61. Global Blood-derived Products Sales (MT) by Application (2026-2031)

Table 62. Global Blood-derived Products Sales Market Share by Application (2020-2025)

Table 63. Global Blood-derived Products Sales Market Share by Application (2026-2031)

Table 64. Global Blood-derived Products Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Blood-derived Products Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Blood-derived Products Revenue Market Share by Application (2020-2025)

Table 67. Global Blood-derived Products Revenue Market Share by Application (2026-2031)

Table 68. Global Blood-derived Products Price (US$/Kg) by Application (2020-2025)

Table 69. Global Blood-derived Products Price (US$/Kg) by Application (2026-2031)

Table 70. Grifols Company Information

Table 71. Grifols Description and Business Overview

Table 72. Grifols Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Grifols Blood-derived Products Product

Table 74. Grifols Recent Developments/Updates

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. CSL Blood-derived Products Product

Table 79. CSL Recent Developments/Updates

Table 80. Takeda Company Information

Table 81. Takeda Description and Business Overview

Table 82. Takeda Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Takeda Blood-derived Products Product

Table 84. Takeda Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. Octapharma Blood-derived Products Product

Table 89. Octapharma Recent Developments/Updates

Table 90. CBPO Company Information

Table 91. CBPO Description and Business Overview

Table 92. CBPO Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. CBPO Blood-derived Products Product

Table 94. CBPO Recent Developments/Updates

Table 95. Hualan Bio Company Information

Table 96. Hualan Bio Description and Business Overview

Table 97. Hualan Bio Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Hualan Bio Blood-derived Products Product

Table 99. Hualan Bio Recent Developments/Updates

Table 100. Kedrion Company Information

Table 101. Kedrion Description and Business Overview

Table 102. Kedrion Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. Kedrion Blood-derived Products Product

Table 104. Kedrion Recent Developments/Updates

Table 105. Shanghai RAAS Company Information

Table 106. Shanghai RAAS Description and Business Overview

Table 107. Shanghai RAAS Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Shanghai RAAS Blood-derived Products Product

Table 109. Shanghai RAAS Recent Developments/Updates

Table 110. LFB Group Company Information

Table 111. LFB Group Description and Business Overview

Table 112. LFB Group Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. LFB Group Blood-derived Products Product

Table 114. LFB Group Recent Developments/Updates

Table 115. Weiguang Bio Company Information

Table 116. Weiguang Bio Description and Business Overview

Table 117. Weiguang Bio Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Weiguang Bio Blood-derived Products Product

Table 119. Weiguang Bio Recent Developments/Updates

Table 120. Tiantan Bio Company Information

Table 121. Tiantan Bio Description and Business Overview

Table 122. Tiantan Bio Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 123. Tiantan Bio Blood-derived Products Product

Table 124. Tiantan Bio Recent Developments/Updates

Table 125. Shuanglin Bio Company Information

Table 126. Shuanglin Bio Description and Business Overview

Table 127. Shuanglin Bio Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 128. Shuanglin Bio Blood-derived Products Product

Table 129. Shuanglin Bio Recent Developments/Updates

Table 130. Boya Bio Company Information

Table 131. Boya Bio Description and Business Overview

Table 132. Boya Bio Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 133. Boya Bio Blood-derived Products Product

Table 134. Boya Bio Recent Developments/Updates

Table 135. Yuanda Shuyang Company Information

Table 136. Yuanda Shuyang Description and Business Overview

Table 137. Yuanda Shuyang Blood-derived Products Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 138. Yuanda Shuyang Blood-derived Products Product

Table 139. Yuanda Shuyang Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Blood-derived Products Distributors List

Table 143. Blood-derived Products Customers List

Table 144. Blood-derived Products Market Trends

Table 145. Blood-derived Products Market Drivers

Table 146. Blood-derived Products Market Challenges

Table 147. Blood-derived Products Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Blood-derived Products

Figure 2. Global Blood-derived Products Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Blood-derived Products Market Share by Type: 2024 & 2031

Figure 4. Albumin Product Picture

Figure 5. Immunoglobulins Product Picture

Figure 6. Coagulation Factors Product Picture

Figure 7. Others Product Picture

Figure 8. Global Blood-derived Products Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Blood-derived Products Market Share by Application: 2024 & 2031

Figure 10. Therapeutics

Figure 11. Excipient

Figure 12. Other

Figure 13. Global Blood-derived Products Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Blood-derived Products Market Size (2020-2031) & (US$ Million)

Figure 15. Global Blood-derived Products Sales (2020-2031) & (MT)

Figure 16. Global Blood-derived Products Average Price (US$/Kg) & (2020-2031)

Figure 17. Blood-derived Products Report Years Considered

Figure 18. Blood-derived Products Sales Share by Manufacturers in 2024

Figure 19. Global Blood-derived Products Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Blood-derived Products Players: Market Share by Revenue in Blood-derived Products in 2024

Figure 21. Blood-derived Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Blood-derived Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Blood-derived Products Sales Market Share by Country (2020-2031)

Figure 24. North America Blood-derived Products Revenue Market Share by Country (2020-2031)

Figure 25. United States Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Blood-derived Products Sales Market Share by Country (2020-2031)

Figure 28. Europe Blood-derived Products Revenue Market Share by Country (2020-2031)

Figure 29. Germany Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Blood-derived Products Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Blood-derived Products Revenue Market Share by Region (2020-2031)

Figure 36. China Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Blood-derived Products Sales Market Share by Country (2020-2031)

Figure 44. Latin America Blood-derived Products Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Blood-derived Products Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Blood-derived Products Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Blood-derived Products Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Blood-derived Products by Type (2020-2031)

Figure 54. Global Revenue Market Share of Blood-derived Products by Type (2020-2031)

Figure 55. Global Blood-derived Products Price (US$/Kg) by Type (2020-2031)

Figure 56. Global Sales Market Share of Blood-derived Products by Application (2020-2031)

Figure 57. Global Revenue Market Share of Blood-derived Products by Application (2020-2031)

Figure 58. Global Blood-derived Products Price (US$/Kg) by Application (2020-2031)

Figure 59. Blood-derived Products Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions